Biotech

Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update

MENLO PARK, CA: ...

Theratechnologies Announces Update from its Healthcare Analyst Day Meeting

MONTREAL, CANADA: ...

Immunovaccine Appoints Gabriela Rosu, M.D., as Company''s First Chief Medical Officer

HALIFAX, NOVA SCOTIA: Seasoned Medical Executive to Drive Advances in Immunovaccine's Expanding Clinical Portfolio ...

Theratechnologies: Results of HIV Biologic and Long-Acting Investigational Antiretroviral Ibalizumab to be Presented in Late-Breaker Session at IDWeek 2016(TM)

MONTREAL, CANADA: Phase III Study Primary Endpoint Results Show Ibalizumab Significantly Reduced Viral Load in Patients with Multi-Drug Resistant HIV-1 ...

Arch Biopartners Collaborates With Team at Cincinnati Veterans Affairs Medical Center to Prepare Phase I and II Human Trial Protocol and Application for AB569

TORONTO, ONTARIO: ...

S2G BioChem Announces Collaboration with Mondelez International for New Sweetener Process

VANCOUVER, BRITISH COLUMBIA: Production of Sustainably-Sourced Food Ingredient Xylitol Expected to Begin in 2018 ...

Angle PLC: Director''s share purchase

SURREY, UNITED KINGDOM: ...

Corcept Therapeutics to Announce Third Quarter 2016 Financial Results and Corporate Update and Host Conference Call

MENLO PARK, CA: ...

Savvy Portfolio Management an Important Key to Superior Value Creation

BOSTON, MA: Leading Value Creators Use Active Portfolio Management to Achieve and Sustain Top Performance, According to the 2016 Value Creators Report from The Boston Consulting Group ...

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2016

TORONTO, ONTARIO: ...